Buspirone Treatment of Cannabis Dependence: A Randomized, Placebo-Controlled Trial

BACKGROUND: The purpose of this study was to evaluate the efficacy of buspirone, a partial 5-HT1A agonist, for treatment of cannabis dependence. METHODS: One hundred seventy-five cannabis-dependent adults were randomized to receive either up to 60 mg/day of buspirone (n=88) or placebo (n=87) for twe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Alcohol Depend
Hlavní autoři: McRae-Clark, Aimee L., Baker, Nathaniel L., Gray, Kevin M., Killeen, Therese K., Wagner, Amanda M., Brady, Kathleen T., DeVane, C. Lindsay, Norton, Jessica
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633378/
https://ncbi.nlm.nih.gov/pubmed/26386827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.08.013
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky